Renal Medullary Crest Necrosis Associated with Phenylbutazone Therapy in Horses
- 1 November 1983
- journal article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 20 (6) , 662-669
- https://doi.org/10.1177/030098588302000602
Abstract
Thirty-five cases of renal medullary crest necrosis morphologically similar to the renal papillary necrosis of analgesic nephropathy as described in man and rats are reported in horses receiving maintenance dosages of phenylbutazone. The primary lesion is a well-demarcated focal medullary necrosis resulting in sequestration of fragments of the renal crest. Renal cortical lesions are considered secondary to the medullary necrosis and consist of segmental pallor as a result of tubular dilatation, filtrate retention, and interstitial edema. Ischemia in concert with phenylbutazone is suggested as the etiology. Renal medullary crest necrosis is presented as more appropriate morphological terminology for this lesion in the equine species than renal papillary necrosis as is used in man and rats.Keywords
This publication has 11 references indexed in Scilit:
- Phenylbutazone toxicity in poniesVeterinary Record, 1979
- Phenylbutazone and the Horse—A ReviewEquine Veterinary Journal, 1977
- Pathology, Aetiology and Pathogenesis of Analgesic Nephropathy*Australian and New Zealand Journal of Medicine, 1976
- Further studies of the acute effects of phenylbutazone, oxyphenbutazone and indomethacin on the rat kidneyPathology, 1976
- Anti-inflammatory drugs and renal papillary necrosisInflammation Research, 1975
- Renal and gastric lesions after phenylbutazone and indomethacin in the ratPathology, 1974
- Medullary Ischaemia in Experimental Analgesic Nephropathy—The Pathogenesis of Renal Papillary Necrosis*Australian and New Zealand Journal of Medicine, 1973
- Papillary Necrosis Following Phenylbutazone IngestionArchives of Surgery, 1971
- LESIONS IN THE VASA RECTA IN EXPERIMENTAL ANALGESIC NEPHROPATHYThe Lancet, 1968
- HISTOLOGICAL CHANGES IN RABBIT KIDNEYS INDUCED BY PHENACETIN AND ACETYLSALICYLIC ACIDThe Lancet, 1964